The Honeybee scandal is back in court. The Economic and Financial Crimes Court has ruled that the Director of Public Prosecutions' appeal against the acquittal of former health minister Dr Chitalu Chilufya may proceed, reopening one of the most notorious procurement cases of the last decade.

The case stems from the supply of defective medicines and medical kits by Honeybee Pharmacy to the public health system — a scandal that broke in 2020, triggered a parliamentary outcry and became a byword for procurement failure. Chilufya, health minister at the time, was acquitted; the DPP signalled its intention to challenge that outcome.

The court's latest ruling does not reverse the acquittal. It clears a procedural path for the appeal to be heard on its merits — a distinction that matters legally, and politically: the case tests whether high-profile acquittals in procurement cases can be revisited.

Health sector campaigners have long argued the Honeybee affair illustrated how defective products reached public facilities through layers of weak oversight. Whatever the appeal's outcome, the case has already reshaped how medical procurement is scrutinised.

Back to the front page